News

FDA Approves Fiasp for Children With Diabetes

The FDA has approved insulin aspart injection (Fiasp, Novo Nordisk), 100 U/mL, as a new mealtime option for children with diabetes—the first fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation. Diabetes is one of the most common chronic conditions of childhood, with nearly 18,000 new cases of type-1 diabetes diagnosed each […]

News

US companies celebrate 25-year commitment to curing type 1 diabetes

A 25-year relationship between two companies committed to curing type 1 diabetes is being celebrated through Diabetes Awareness Month. In 1994, the Diabetes Research Institute (DRI) teamed up with Biorep Technologies Inc, a Miami-based company that manufactures critical research equipment. The partnership began when Biorep founder Ramon Poo became involved with the DRI after his […]